PKM and cancer: By delineating the manner in which circABCC4 modulates PKM2 and activates glycolysis within CAFs, our research identifies this molecular interaction as a strategic target to bolster the effectiveness of platinum-based chemotherapy in PDAC, thereby advancing the frontier of cancer therapeutics.